000801120 000__ 05177cam\a2200481Ii\4500
000801120 001__ 801120
000801120 005__ 20230306143617.0
000801120 006__ m\\\\\o\\d\\\\\\\\
000801120 007__ cr\un\nnnunnun
000801120 008__ 171011t20172017sz\a\\\\ob\\\\000\0\eng\d
000801120 019__ $$a1005967434
000801120 020__ $$a9783319658537$$q(electronic book)
000801120 020__ $$a3319658530$$q(electronic book)
000801120 020__ $$z9783319658513
000801120 020__ $$z3319658514
000801120 035__ $$aSP(OCoLC)on1005877842
000801120 035__ $$aSP(OCoLC)1005877842$$z(OCoLC)1005967434
000801120 040__ $$aYDX$$beng$$erda$$cYDX$$dN$T$$dGW5XE$$dN$T$$dMMU$$dOCLCO$$dOCLCF$$dTFH$$dOCLCO$$dUAB$$dOCLCO
000801120 049__ $$aISEA
000801120 050_4 $$aRM301.41
000801120 08204 $$a615.1/9$$223
000801120 24500 $$aSigma proteins :$$bevolution of the concept of sigma receptors /$$cFelix J. Kim, Gavril W. Pasternak, editors.
000801120 264_1 $$aCham, Switzerland :$$bSpringer,$$c[2017]
000801120 264_4 $$c©2017
000801120 300__ $$a1 online resource (viii, 330 pages) :$$billustrations.
000801120 336__ $$atext$$btxt$$2rdacontent
000801120 337__ $$acomputer$$bc$$2rdamedia
000801120 338__ $$aonline resource$$bcr$$2rdacarrier
000801120 4901_ $$aHandbook of experimental pharmacology,$$x1865-0325 ;$$vvolume 244
000801120 504__ $$aIncludes bibliographical references.
000801120 5050_ $$aIntroduction to sigma proteins: evolution of the concept of sigma receptors / Felix J. Kim -- Structural insights into sigma1 function / Andrew Kruse -- 3d homology model of sigma1 receptor / Erik Laurini, Domenico Marson, Maurizio Fermeglia, Sabrina Pricl -- Medicinal chemistry of [sigma]1 receptor ligands: pharmacophore models, synthesis, structure affinity relationships, and pharmacological applications / Frauke Weber, Bernhard Wünsch -- Sigma-1 ([sigma]1) receptor in memory and neurodegenerative diseases / Tangui Maurice, Nino Goguadze -- Sigma-1 receptor and neuronal excitability / Saïd Kourrich -- Sigma-1 receptor and pain / Manuel Merlos, Luz Romero, Daniel Zamanillo, Carlos Plata-Salamán, José Miguel Vela -- Allosteric modulation of opioid g-protein coupled receptors by sigma1 receptors / Gavril W. Pasternak -- A role for sigma receptors in stimulant self-administration and addiction / Jonathan L. Katz, Takato Hiranita, Weimin C. Hong, Martin O. Job, Christopher R. McCurdy -- Sigma receptors and alcohol use disorders / Valentina Sabino, Pietro Cottone -- Sigma1 pharmacology in the context of cancer / Felix J. Kim, Christina M. Maher -- Molecular probes for imaging the sigma-2 receptor: in vitro and in vivo imaging studies / Chenbo Zeng, Elizabeth S. McDonald, Robert H. Mach.
000801120 506__ $$aAccess limited to authorized users.
000801120 520__ $$a"Two sigma receptor subtypes have been proposed, sigma1 and 2. Much of our understanding of this system is based on biochemical and pharmacological characterization of the cloned sigma1 receptor subtype (Sigma1). It has become clear that sigma receptors are not canonical receptors. Sigma1 is highly conserved among mammalian species, however, it does not share significant homology with any other mammalian protein. Although a range of structurally diverse small molecules bind Sigma1 with high affinity, and it has been associated with a broad range of signaling systems, Sigma1 itself has no known signaling or enzymatic activity. The evolution of this field over nearly four decades has more recently led to a fundamental shift in the concept of “sigma receptors” to what may more accurately and generally be called sigma proteins. Largely based on traditional pharmacologic approaches, the Sigma1 protein has been associated with a broad range of signaling systems, including G-protein coupled receptors, NMDA receptors, and ion channels. Sigma proteins have been linked to a range of physiological processes, including intracellular calcium signaling, neuroprotection, learning, memory, and cognition. Emerging genetic, clinical, and mechanism focused molecular pharmacology data demonstrate the involvement of proteins in a range of pathophysiologies and disorders including neurodegenerative disease, pain, addiction, psychomotor stimulant abuse, and cancer. However, an understanding of the physiological role of sigma proteins has remained elusive. Emerging data associate Sigma1 with chaperone-like activities or molecular scaffold functions. This book aims to provide an updated perspective on this rapidly evolving field undergoing changes in fundamental concepts of key importance to the discipline of pharmacology. It focusses on the reported roles of sigma proteins in pathophysiology and on emergent therapeutic initiatives"--Publisher's description.
000801120 588__ $$aDescription based on online resource; title from electronic title page (SpringerLink, viewed November 2, 2017).
000801120 650_0 $$aSigma receptors.
000801120 7001_ $$aKim, Felix J.,$$eeditor.
000801120 7001_ $$aPasternak, Gavril W.,$$eeditor.
000801120 77608 $$iPrint version:$$tSigma proteins.$$dCham : Springer, [2017]$$z9783319658513$$w(DLC)  2017944085$$w(OCoLC)1007835116
000801120 830_0 $$aHandbook of experimental pharmacology ;$$vv. 244.$$x0171-2004
000801120 852__ $$bebk
000801120 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-65853-7$$zOnline Access$$91397441.1
000801120 909CO $$ooai:library.usi.edu:801120$$pGLOBAL_SET
000801120 980__ $$aEBOOK
000801120 980__ $$aBIB
000801120 982__ $$aEbook
000801120 983__ $$aOnline
000801120 994__ $$a92$$bISE